Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Myelodysplastic syndromes (MDS) comprise a heterogeneous group of myeloid neoplasms characterized by peripheral cytopenia, dysplasia, and a variable clinical course with about 30% risk to transform to secondary acute myeloid leukemia (AML). In the past 15 years, diagnostic evaluations, prognosticati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Valent, Peter, Orazi, Attilio, Steensma, David P., Ebert, Benjamin L., Haase, Detlef, Malcovati, Luca, van de Loosdrecht, Arjan A., Haferlach, Torsten, Westers, Theresia M., Wells, Denise A., Giagounidis, Aristoteles, Loken, Michael, Orfao, Alberto, Lübbert, Michael, Ganser, Arnold, Hofmann, Wolf-Karsten, Ogata, Kiyoyuki, Schanz, Julie, Béné, Marie C., Hoermann, Gregor, Sperr, Wolfgang R., Sotlar, Karl, Bettelheim, Peter, Stauder, Reinhard, Pfeilstöcker, Michael, Horny, Hans-Peter, Germing, Ulrich, Greenberg, Peter, Bennett, John M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Priority Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650276/
https://ncbi.nlm.nih.gov/pubmed/29088721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars